Objective To observe the efficacy, toxicity and survival of Taxotere and Cisplatin regimen in advanced non?- small cell lung cancer.

Preparation and properties of Taxol noxionic surfactant vesicles(niosomes)of tween 60;

The role of Taxol on the cell cycle retardation,apoptosis by radioactive rays in Nasopharyngeal Carcinoma cell line in vitro;

Taxol combined with oxaliplatin regimen for advanced non-small cell lung cancer of 43 cases;

Clinical Study of Combined Chemotherapy of Paclitaxel or Docetaxel PlusCisplatn for Non-Small Cell Lung Cancer;

Effect of Survivin shRNA on Chemosensitivity of Human Ovarian Cancer Cell Line OVCAR3 to Paclitaxel;

Paclitaxel(135 mg/m2) was administered to the control group by intravenous drip for three hours on the first day,carboplatin(AUC 5) was given on the first day and the twenty-first day for a cycle.

AS-CLB1 Enhances the Inhibitory Effect of Taxotere on the Proliferation of Lewis Lung Carcinoma Cells in vitro and in vivo;

Inhibitory Effect of Antisense RNA Targeting survivin Gene Combined with Taxotere on Transplanted Multidrug Resistant Colorectal Carcinoma in Nude Mice;

Enhancement of FG020326 on Sensitivity of MCF-7/ADR Cells to Taxotere via Enha ncing Activation of Caspase-8 and Caspase-3;

Effect of weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma;

Comparison of Efficacy of Docetaxel Combined Cisplatin (TP Regimen) and Cisplatin Combined 5-Fluorouracil (PF Regimen) on Locally Advanced Nasopharyngeal Carcinoma;

Clinical Study of Combined Chemotherapy of Paclitaxel or Docetaxel PlusCisplatn for Non-Small Cell Lung Cancer;